StonvexLoading…
StonvexStonvexStonvexCore line items from OXM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $1.48B | $1.10B | $796.00M | $392.86M |
Operating Income | $-31.28M | $-23.48M | $61.62M | $36.21M |
Net Income | $-27.89M | $-20.81M | $42.87M | $26.18M |
EPS (Diluted) | $-1.86 | $-1.39 | $2.83 | $1.70 |
Total Assets | $1.31B | $1.28B | $1.32B | $1.34B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $8.13M | $7.98M | $6.88M | $8.18M |
Free Cash Flow OCF − CapEx | $11.31M | $-22.98M | $24.95M | $-27.37M |
Shares Outstanding | 15.00M | 14.99M | 15.18M | 15.40M |